Sigma Planning Corp Repligen Corp Transaction History

Sigma Planning Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$161.19 - $257.96 $187,625 - $300,265	-1,164 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$247.59 - $304.47 $990 - $1,217	4 Added 0.34%	1,164 $308,000
Q3 2021 Oct 28, 2021	SELL	$194.77 - $324.21 $9,738 - $16,210	-50 Reduced 4.13%	1,160 $335,000
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $19,406 - $25,851	-117 Reduced 8.82%	1,210 $242,000
Q1 2021 May 06, 2021	BUY	$180.37 - $226.26 $26,514 - $33,260	147 Added 12.46%	1,327 $258,000
Q4 2020 Feb 09, 2021	BUY	$148.08 - $206.57 $174,734 - $243,752	1,180 New	1,180 $226,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.